Increased prevalence of antibrain antibodies in the sera from schizophrenic patients

Schizophrenia Research

Volumn 14, Issue 1, 1994, Pages 15-22

  Henneberg, A E ^a   Horter, S ^a   Ruffert, S ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

(Schizophrenia); Anti brain antibodies; Autoimmune disease

Indexed keywords

BRAIN ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REGIONALIZATION; SCHIZOPHRENIA;

ACUTE DISEASE; ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BINDING SITES, ANTIBODY; BRAIN; BRAIN MAPPING; CELL LINE; FEMALE; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0028073036     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(94)90004-3     Document Type: Article

References (79)

1. Counterpoint: A sensory gating-hippocampal model of schizophrenia
2. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia
3. The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells
4. Tissue-binding factor in schizophrenic sera: a clinical and genetic study
5. Immunologic studies in schizophrenic and control subjects
6. Chlorpromazine-induced antinuclear factor
7. Demonstration of nuclear and cytoplasmic fluorescence in brain tissues of schizophrenic and nonschizophrenic patients
8. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage
9. The frontal lobes, basal ganglia, temporal lobes as sites for schizophrenia
10. Schizophrenia: some new aetiological considerations
11. Astrocytosis in the molecular layer of the dentate gyrus: A study in Alzheimer's disease and schizophrenia
12. Elevated IGG antihistone antibodies in a subgroup of medicated schizophrenic patients
13. The prevalence of autoantibodies among right and left handed schizophrenic patients and control subjects
14. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon
15. Is schizophrenia a viral or immunologic disorder?
16. Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus
17. Abnormal immune regulation in schizophrenic patients
18. Failure to detect immunologic stigmata in schizophrenia
19. Limbic pathology in schizophrenia: the entorhinal region - a morphometric study
20. The ‘antibrain’ factors in psychiatric patients'sera
21. Sigma receptors and autoimmune mechanisms in schizophrenia: preliminary findings and hypotheses
22. Clinical and laboratory evidence of autoimmunity in acute schizophrenia
23. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
24. Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques
25. Antiseptal brain antibody in IgG of schizophrenic patients
26. Hippocampal neuron number in schizophrenia: A stereological study
27. Antibrain antibodies in alcoholic patients
28. Antibodies to brain tissue in sera of patients with chronic progressive multiple sclerosis
29. T-lymphocyte subpopulations in schizophrenic patients
30. Autoantibodies in sera of schizophrenic patients
31. Autoantikörper bei Schizophrenie
32. Antibodies to brain tissue in sera of schizophrenic patients - preliminary findings
33. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment
34. Cytotoxic anti-lymphocyte antibody in schizophrenics
35. Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia
36. Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiogr aphy
37. Antibodies to the human 60kDa heat-shock protein in patients with schizophrenia
38. Is schizophrenia a virally triggered antireceptor autoimmune disease?
39. Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia
40. Blood lymphocytes in schizophrenia - immunological and virological aspects
41. A neuroimmunological challenge: schizophrenia as an autoimmune disease
42. Le decélement d'anticorps du cerveau dans le serum des malades d'affections neuro-psychiques
43. Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit
44. B cell and autoantibody repertoire in a pair of monozygotic twins discordant for myasthenia gravis
45. Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders
46. Über die Liquordiagnose der Schizophrenien
47. Schizophrenia, an immunologic disorder?
48. Antibodies to thymocytes in sera of patients with schizophrenia
49. Schizophrenia and autoimmune serological reactions
50. Quantifizierung zellulärer Immunfunktionen als State- bzw. Trait-Marker
51. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic
52. Autoimmune model of schizophrenia with special reference to antibrain antibodies
53. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain fu nction
54. Autoantibodies to brain lipids in schizophrenia
55. Brain magnetic resonance imaging: Approaches for investigating schizophrenia
56. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
57. Myelin basic protein antibodies in catatonic schizophrenia
58. Annotation: Notes from the graveyard: Neuropathology and schizophrenia
59. Investigation of precipitins to human brain in sera of psychotic patients
60. Antibodies against serotonin and gangliosides in schizophrenia and major depressive disorder
61. Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia. Olfactory identification and Wisconsin Card Sorting Performance
62. Anticerebral antibodies in functional psychoses
63. Platelet autoantibodies in dementia and schizophrenia: Possible implication for mental disorders
64. Antinuclear factor in psychiatric patients
65. Cold agglutinin autoantibodies in psychiatric patients: Their relation to diagnostic and pharmacological treatment
66. Schizophrenia and multiple sclerosis
67. Antibody reactivity to brain membrane proteins in serum from schizophrenic patients
68. Laboratory investigations in clinical immunology: methods, pitfalls and clinical indications
69. Midsagittal cortical pathomorphology of schizophrenia: A magnetic resonance imaging study
70. Aspects of humoral and cellular immunity in schizophrenia
71. Anti-histone antibodies in schizophrenia and affective disorders
72. Antinuclear factor in psychiatric disorder
73. Antithymic antibodies in schizophrenic sera
74. Hippocampal injury and chronic schizophrenia
75. Absence of brain antibodies in patients with schizophrenia
76. Correlation of negative symptoms in schizophrenia with frontal lobe parameters on magnetic resonance imaging
77. A tissue-binding factor in the serum of schizophrenic patients
78. Factors related to the presence of autoantibodies in patients with chronic mental disorders
79. Immunologic and coagulation disorders in chlorpromazine-treated patients